Meeting, PA); PAF and unlabeled nucleotides (Bachem Biosciences, Philadelphia, PA); RANTES and IL-8 (R&D Systems, Minneapolis MN) Ci/mol (DuPont-New England Nuclear, Boston, MA); Ready Safe Scintillation fluid (Beckman, Fullerton, CA); cytochalasin B and diisopropylfluorophosphate (Aldrich Chemicals, Milwaukee, WI); enhanced chemiluminescence (ECL) kits and nitrocellulose membranes (Amersham, Arlington Heights, IL); HRP-linked goat Ab to rabbit IgG (Transduction Labs, Lexington, KY); polyclonal Ab to a C-terminal peptide of ␣ i1 /␣ i2 (catalog number 371776) , polyclonal Ab to a C-terminal peptide of ␣ i3 (371729), polyclonal Ab to an internal peptide of ␣ common (371737; reacts with ␣ s , ␣ i1 , ␣ i2 , ␣ i3 , ␣ o , ␣ t , and ␣ z ), polyclonal Ab to a C-terminal peptide of ␣ 12 (371778), and immunizing peptide for anti-␣ 13 C terminus Ab (Calbiochem, La Jolla, CA); polyclonal Ab to an N-terminal peptide of ␣ q (catalog number sc-393), polyclonal Ab to a C-terminal peptide of ␣ q/11 (sc-392), polyclonal Ab to an N-terminal peptide of ␣ 11 (sc-394), polyclonal Ab to an N-terminal peptide of ␣ 13 (sc-410), polyclonal Ab to a C-terminal peptide of ␣ 16 (sc-7415), and immunizing peptide for anti-␣ q/11 Ab (Santa Cruz Biotechnology, Santa Cruz, CA); and mAb to r␣ i2 (catalog number MAB3077) and polyclonal Ab to a C-terminal peptide of ␣ 13 (AB1651)(Chemicon International, Temecula, CA). Polyclonal Ab to an N-terminal peptide of ␣ z and a positive control from lysed human platelets were a generous gift from Dr. A. Nixon and P. J. Casey, Departments of Molecular Cancer Biology and Biochemistry (Durham, NC). Cells and stimuli were suspended in modified Hanks' buffer containing 1.4 mM CaCl 2 , 12.5 g/ml BSA, and 10 mM D-glucose for chemotaxis; this buffer but with no glucose for hexose uptake; relaxation buffer for Percoll gradient fractionation; or binding buffer for GTP␥S-binding assays (10) .
Cell isolation, PT treatment, and assays of function
We isolated PMN (Ͼ95% PMN, Ͻ5% Eo, Ͻ2% monocytes, Ͻ5 platelets/ 100 cells, no erythrocytes) from human donor blood and Eo (Ͼ95% Eo, Ͻ3% PMN, Ͻ3% monocytes) from PMN preparations by CD16-negative selection (4) . Cells (2 ϫ 10 7 /ml Ca 2ϩ -free buffer) were treated with PT (37°C) for 2 h, washed twice in Ca 2ϩ -free buffer, and suspended in Ca 2ϩ -containing buffer. Chemotaxis was assayed under agarose (2.5 gm% (w/v) agarose in MEM plus 2.5% (v/v) newborn calf serum). Aliquots (10 l) of stimuli, 5 ϫ 10 5 cells, and Hanks' buffer were placed in 60-mm-spaced outer, center, and inner wells. Reactions were incubated at 37°C for 3 h under an atmosphere of 5% CO 2 ; fixed in 2.5% gluteraldehyde; stained for granulocytes; and microscopically examined for distance between the leading front of Ն3 cells to the edge of the well of origin (4) . Results are reported in migration indices, i.e., the mm of migration to stimuli minus that to buffer. Movements toward buffer-containing wells averaged 0.05 mm for PMN or 0.02 mm for Eo. To assay hexose uptake, 6 ϫ 10 5 PMN were incubated in 200 l of glucose-free buffer, challenged (37°C) for 10 min, exposed to 60,000 dpm of [ 14 C]DOG in 100 l of buffer, and incubated for 1 h. Reactions were diluted with 1 ml of 4°C glucose-free buffer, placed on ice, centrifuged (12,000 ϫ g, 5 s, 4°C), suspended in 4°C buffer, and again centrifuged to obtain pellets that were solubilized in 2 ml of scintillation fluid and counted for label. Results are in percentage of added radioactivity that was cell associated. When indicated, PMN were incubated with D-glucose, L-glucose, or cytochalasin B for 10 min before challenge.
Percoll gradients
PMN were treated with 2 mM diisopropylfluorophosphate; washed; suspended (3 ϫ 10 8 cells) in 7 ml of relaxation buffer; subjected to N 2 -cavitation; treated with 2 mM EGTA, 50 mM 2-ME, and 1 mM PMSF; freed of nuclei and unbroken cells by low-speed centrifugation; and resolved on discontinuous Percoll gradients into 21 fractions that were enriched with markers for: cytosol (lactate dehydrogenase, fractions 1-4); plasma membranes (surface alkaline phosphatase, fractions 5-8); light Golgi (UDPgalactose: N-acetyl-glucosamine galactosyltransferase, fractions 5-8); secretory vesicles (latent alkaline phosphatase, fractions 7-11); secondary granules (myeloperoxidase, fractions [13] [14] [15] [16] ; heavy Golgi (UDP-galactose:N-acetyl glucosamine galactosyltransferase, fractions 13-16); and primary granules (␤-glucuronidase, fractions 18 -21) (10). Cytosol, plasma membrane, and granule fractions were pooled and centrifuged (200,000 ϫ g, 2 h, 4°C). Supernatants from cytosol were treated with pepstatin (25 g/ml), leupeptin (40 g/ml), aprotinin (0.05 U/ml), PMSF (1 mM), soybean trypsin inhibitor (10 g/ml), benzamidine (3 mM), DTT (1 mM), and SDS (1% [w/v]). Pellets were washed twice and suspended to original volume in buffer containing these inhibitors. Where indicated, secondary and primary granule pools were suspended to half original volume and combined. In other studies, PMN or Eo (1.5 ϫ 10 7 per ml of Hanks' buffer; no Ca 2ϩ ) were suspended with the inhibitors given above (including 2 mM diisopropylfluorophosphate); sonicated at 4°C (three 10-s strokes; setting of 2; Heat Systems, Model W220, St. Louis MO); treated with SDS; and centrifuged (240,000 ϫ g, 20 min, 20°C). Supernatants were isolated and pellets brought to original volume in buffer with the same inhibitors.
Western blots
Pools of cell fractions were placed in boiling water for 5 min. Samples (30 -80 l, equal to 1-3 ϫ 10 6 cells) were run on SDS-PAGE (5% loading/ 10% separating gels (37.5:1 bis-polyacrylamide)) to 9 cm at 35 mA for 5 h and electrotransferred to nitrocellulose at 100 mA for 16 h. The blots were washed in TBS (10 mM Tris, 100 mM NaCl, pH 7. 
Assay of GP activity
PMN (1 ϫ 10 8 per ml of HBSS buffer (no added Ca 2ϩ or Mg 2ϩ )) were incubated at 37°C for 2 h with 0 -2 g/ml of PT. Cells were washed and suspended in isotonic saline (4°C), incubated (5 ϫ 10 7 /ml) with 2 mM diisopropylfluorophosphate for 5 min, twice washed in isotonic saline, and suspended at 2 ϫ 10 8 /ml in HBSS buffer (no Ca 2ϩ or Mg 2ϩ ) with 2 mM EGTA, 50 mM 2-ME, and 1 mM PMSF. Suspensions were sonicated and centrifuged (100,000 ϫ g; 1 h; 4°C); pelleted membranes were taken up in binding buffer. Aliquots (100 l) of membranes equivalent to 3 ϫ 10 5 PMN were incubated at 30°C with 50 pM [ 35 S]GTP␥S (Ϯ100 M GTP␥S), 320 nM GDP, 50 g BSA, and a stimulus, and passed through G/FC filters. Filters were washed five times with 1 ml of buffer (50 mM triethanolamine, 4 mM MgCl 2 , pH 7.4, 4°C); air dried; incubated for 10 min with methanol (250 l); suspended in 2 ml of scintillation fluid; and counted for radioactivity. We defined specific binding as the fraction of added radiolabel bound by membranes incubated with 50 pM [ 35 4 in the presence or absence of other agents. Reactions were passed through GF/C filters and washed five times with 1 ml of Hanks' buffer (no glucose, 1.4 mM Ca 2ϩ , and 0.7 mM Mg 2ϩ , 4°C). Filters were air dried, treated with methanol (250 l) for 10 min, mixed with 2 ml of scintillation fluid, and counted for radioactivity.
Ligand metabolism
Mixed membranes from sonicated PMN were treated with 12.5 M triacsin C and incubated with 100 pM of 
Results

PMN incubated with [
14 C]DOG progressively took up radioactivity for Ͼ1.5 h, and various agents induced an increase in this uptake. Fig. 1 illustrates these responses as they occurred after 1 h of challenge. Cytochalsin B, which blocks the glucose transporter, and D-glucose, but not L-glucose, abrogated the uptake of [ 14 C]DOG in both resting and challenged cells (Table I) . Thus, the responses of Fig. 1 are due to the stimulation of a constitutively active, stereospecific hexose carrier. PT blocked the actions of CF, but did not alter hexose uptake in resting cells (data not shown) nor inhibit agents that operate independently of GP viz, PMA, ionomycin, or TNF-␣ (Fig. 2) . Among the CF, however, PAF had minimal, and C5a, FMLP, IL-8, and LTB 4 only partial sensitivity to PT. Indeed, PMN treated with even 16 g/ml of the toxin took up significant amounts of DOG in response to these CF. In sharp contrast, 1 g/ml of PT almost completely abrogated the action of 5-oxoETE ( Fig. 2) as well as rac-5-HETE (data not shown). PT likewise only partly blocked PMN and Eo chemotactic responses to C5a, FMLP, PAF, and LTB 4 ( Fig. 3) . In studies not shown, it also blocked PMN migration to 2.5 or 25 nM IL-8 by less than 70% at 16 g/ml and Eo migration to 25 or 100 nM RANTES by less than 60% at 4 g/ml (16 g/ml of PT clumped Eo). The toxin again had a far greater impact on 5-oxoETE, totally blocking the responses of both cell types to the eicosanoid at Ͼ1 g/ml (Fig. 3) . We conclude that 5-oxoETE analogues exhibit a singularly high sensitivity to PT. We next determined whether this effect is realized at the level of GP.
In the presence of [ 35 S]GTP␥S (50 pM), membranes from sonicated PMN incorporated radioactivity progressively over 60 min, after which apparent equilibrium occurred. This incorporation was due to the specific binding of the label since Ͼ1 M of GTP␥S displaced [ 35 S]GTP␥S by Ͼ90% (data not shown). GDP had a similar effect, reducing [ 35 S]GTP␥S binding by 50% and 90% at 300 and 1000 M, respectively (data not shown). Given these results, the binding of label to membranes incubated with 50 pM of [ 35 S]GTP plus 320 nM of GDP reflects competition between [ 3 H]GTP␥S and GDP for a common acceptor (10, 31) . In the presence of 320 M of GDP, CF stimulated the incorporation of radioactivity into membranes, i.e., increased the binding of [ 35 S]GTP␥S relative to GDP. The most active agent, LTB 4 , was ϳ3-fold more powerful than 5-oxoETE or rac-5-HETE (Fig. 4 ) and 1.3-to 2.5-fold more powerful than FMLP, C5a, IL-8, or PAF (data not shown). To examine the effect of PT on these responses, we treated PMN with PT for 2 h, sonicated the cells, isolated their membranes, and stimulated these membranes with an optimally effective and at least one lower concentration of each CF. Membranes from PMN treated with 0.5 or 2 g/ml PT had greatly reduced responses to 5-oxoETE compared with those to FMLP, C5a, IL-8, PAF, or LTB 4 (Fig. 5) . Unlike the latter agents, then, 5-oxoETE induces the exchange of [
35 S]GTP␥S for GDP preferentially in PT-sensitive GP. This could be due to a paucity of 5-oxoETE binding sites if the G i subfamily has a predilection over other subfamilies for receptor coupling. That is, G i heterotrimers might tie up a sparsely represented receptor type, effectively excluding it from interacting with other heterotrimers (31). We accordingly enumerated 5-oxoETE and LTB 4 binding sites.
PMN membranes treated with triacsin C (to block acylation of 5-oxoETE into glycerolipids (11) 4 binding to the membranes followed a similarly rapid FIGURE 2. Effects of PT on hexose uptake responses. PMN were treated with PT at 37°C for 2 h, washed, and stimulated, as described in Fig. 1 . Results are the mean (ϮSEM; n Ն 5) percentages of added label taken up by challenged cells above that taken up by BSA-treated cells. PT by itself did not inhibit hexose uptake in resting cells (data not shown).
FIGURE 3.
Effect of PT on chemotaxis. PMN (left panels) and Eo (right panels) were incubated with 0 -16 g/ml PT for 2 h, washed, and assayed. The amounts of stimuli selected for study were those producing optimal as well as suboptimal response magnitudes in pilot experiments. Results (means Ϯ SEM, n Ն 6 -9) are in mm of movement toward the indicated stimuli minus that toward BSA. Note the different y-axis scales. (Table II) . Although there was a large difference in the specific binding of 5-oxoETE and LTB 4 , Scatchard analysis revealed that this resulted from the ϳ30-fold greater K d of high-and low-affinity receptors for LTB 4 , relative to the comparable K d values for 5-oxoETE. 5-OxoETE actually bound to more high-and low-affinity sites than LTB 4 (Fig. 7) . Evidently, then, 5-oxoETE binding sites do not interact appreciably with LTB 4 , LXA 4 , or LXB 4 , and the different PT sensitivities of 5-oxoETE and LTB 4 are not explained by a simple quantitative difference in their respective binding sites.
In a final set of studies, soluble and particulate fractions from sonicated PMN were resolved by electrophoresis, transferred to membranes, and examined for ␣-chains. Ab to ␣ common (data not shown), r␣ i2 (Fig. 8, left panel) , and ␣ i2 C terminus (data not shown) reacted with a 42-kDa band in particulate but not soluble fractions. Anti-␣ i3 C terminus Ab, which reacts with ␣ i2 and ␣ i3 , and Ab to the N terminus of ␣ i2 , also detected this band (data not shown). We further observed that Ab to the common C terminus of ␣ q and ␣ 11 recognized a particulate but not soluble band at 44 kDa (Fig. 8, left panel) . Blots probed with anti-r␣ i2 Ab, stripped, and probed with Ab to ␣ q/11 , or blots probed with these Ab in the opposite sequence revealed that ␣ i2 moved faster than ␣ q/11 . Ab to the N terminus of ␣ q and Ab to the N terminus of ␣ 11 also reacted with the latter band (data not shown). We therefore identify the 44-kDa Ag as ␣ q/11 . Finally, anti-␣ 13 C terminus Ab detected a band at 43 kDa in particulate but not soluble PMN fractions (Fig.  8, right panel) . Sequential probing and stripping experiments indicated this band moved between ␣ i2 and ␣ q/11 . However, fractions stored at Ϫ20°C instead of examined immediately after isolation had a band at 41 in addition to 43 kDa that reacted with Ab to the C terminus of ␣ 13 . Only the 43-kDa band reacted with Ab to ␣ 13 N terminus (Fig. 8, right panel) . Thus, PMN express ␣ i2 and ␣ q/11 , 4 ) PMN were incubated for 30 min at 37°C with 12.5 M triacsin C, treated with 100 pM of an indicated radioligand, with or without an eicosanoid, passed through GF/C filters, and counted for radioactivity. For studies with nucleotide, membranes were treated with GTP␥S or ATP␥S for 30 min before exposure to radiolabel.
b Mean percentage of added radioactivity Ϯ SEM, for Ն5 experiments, bound by membranes incubated with the indicated radioligand and agent minus that of membranes incubated with [ but not ␣ 16 . They also express ␣ 13 , which, it appears, is subject to N-terminal degradation during storage.
To confirm these results and examine the compartmentalization of GP, nitrogen cavitates of PMN were separated into cytosol, plasma membrane, secondary granule, and primary granule fractions by centrifugation through Percoll gradients. Plasma membranes and secondary granules, but neither cytosol nor primary granules, had a 42-kDa band reacting with anti-r␣ i2 Ab, as well as a 44-kDa band reacting with anti-␣ q/11 Ab. Ab to the C terminus of ␣ 13 detected a 41-kDa band in plasma membrane (Fig. 9, upper  panel) . Since Ab to the N terminus of ␣ 13 did not detect this band (data not shown), it is likely that ␣ 13 suffered N-terminal degradation during the several hours required to fractionate PMN on Percoll gradients. In any event, the bands detected with Ab to ␣ i2 , ␣ q/11 , and ␣ 13 migrated with their counterparts from sonicated PMN (data not shown), and ␣ q/11 and ␣ 13 were further distinguished from each other by immunizing peptides. These peptides blocked reactions to the cognate, but not opposite Ab (Fig. 9, lower  panel) . Finally, anti-␣ z Ab, while readily reacting with a 42-kDa band in the lysates of human platelets, detected no such band in PMN Percoll gradient fractions. Ab to ␣ 12 and Ab to ␣ 16 also gave negative results in Percoll gradient as well as sonicated PMN fractions (data not shown). Evidently, then, ␣ i2 and ␣ q/11 reside in PMN plasma membranes and secondary granules, whereas ␣ 13 localizes only to plasma membranes. PMN do not have measurable amounts of ␣ z , ␣ 12 , or ␣ 16 , at least when examined with the methods and Ab used in this study. and LTB 4 (lower panel) to mixed membranes from PMN sonicates. All data (n Ն 9) are corrected for nonspecific binding, as determined using the LIGAND program. LIGAND indicated that both 5-oxoETE and LTB 4 bound to high-(R 1 ) and low-(R 2 ) affinity sites (p Յ 0.05, F-distribution), the numbers per cell (R t ), and K d values of which are given in each panel.
FIGURE 9.
The distribution of GP in PMN. N 2 -cavitated PMN were separated on Percoll gradients into cytosol (C), plasma membrane (PM), primary granule (G1), and secondary granule (G2) fractions. Fractions were processed to obtain Western blots. Arrows refer to positions of molecular mass (kDa) standards in marker lanes (M). Upper panel, Bands reacting with mAb to ␣ i2 (left C, PM, G 1 , and G 2 lanes) or polyclonal Ab to ␣ q/11 (center four lanes) are in plasma membrane and secondary granule fractions. A band reacting with Ab to the C terminus (right four lanes), but not N terminus (data not shown), of ␣ 13 is restricted to plasma membrane fractions and migrates with the fast band in Fig. 8 , center C-ter blot of ␣ 13 . Lower panel, Blots (G 1 and G 2 are combined into G fractions) were probed with Ab to ␣ q/11 (left) or the C terminus of ␣ 13 (right) in the absence or presence of immunizing peptide to the noted ␣-chain. Results are representative of four (upper panel) or two (lower panel) studies.
Eo were sonicated and isolated as soluble and pelleted fractions in tandem with PMN from the same donor. Paired fractions from Eo and PMN were loaded in adjacent lanes and resolved on SDS/ PAGE, transferred to membranes, and probed with Ab. Eo had particulate but no soluble bands at 44 and 42 kDa reactive to antir␣ i2 and ␣ q/11 Ab, respectively. The latter bands migrated with their counterparts from PMN (Fig. 8, left panel) . However, Eo from six of six donors did not exhibit a band reacting with Ab to the N terminus or C terminus of ␣ 13 (results not shown). Thus, Eo membranes express ␣ i2 and ␣ q/11 , but not ␣ 13 .
Discussion
In agreement with others (24 -30), we observe that PMN and Eo express ␣ i2 (Fig. 8, upper panel) . We cannot agree, however, with a report (28) finding no ␣ q/11 in PMN. Rather, we confirm studies (26, 27) finding PMN have a band that reacts with Ab to the common C terminus of ␣ q and ␣ 11 (Fig. 8, left panel) . The band also: reacted with Ab to the N terminus of ␣ 11 and Ab to the N terminus of ␣ q (these termini are structurally similar); moved at 44 kDa, similar to authentic ␣ q and ␣ 11 (27) ; localized to plasma membranes and secondary granules (Fig. 9, upper panel) ; did not react with Ab in the presence of immunizing peptide (Fig. 9 , lower panel); and occurred in the particulate fraction of sonicated Eo (Fig. 8, left panel) . In addition, PMN, but not Eo, had a plasmalemma band reactive with two different Ab to ␣ 13 . This band migrated at 43 kDa (Fig. 8, left panel) , the same rate found in other cells (32) , and was not detectable in the presence of immunizing peptide (Fig. 9, lower panel) . Finally, PMN (data not shown), similar to Eo (30) , lacked a band reacting with Ab to ␣ z . PMN also failed to express material reactive with Ab to ␣ 12 or ␣ 16 . Tenailleau et al. (27) , while not finding ␣ 12 in PMN, did detect a faint doublet with Ab that, unlike our anti-␣ 16 C-terminal Ab, was directed to the N terminus of ␣ 16 . This may indicate that ␣ 16 is degraded at its C terminus during cell processing. However, the findings of Tenailleau et al. could be due to monocyte contamination since these cells express high levels of ␣ 16 (27) . In any event, PMN express at the very least PT-sensitive ␣ i2 and PT-resistant ␣ q/11 , ␣ 13 , and perhaps a trace of ␣ 16 , while Eo express ␣ i2 and ␣ q/11 . These results allow a possibility that the PT-resistant responses actuated by transfected CF receptors are mediated by an unsuspected coupling of these receptors to ␣ 13 , the presence of which was not sought in recipient model cells (9 -13) . They may also pertain to PMN.
C5a, FMLP, PAF, LTB 4 , IL-8, and RANTES elicited PMN and Eo chemotaxis and PMN hexose uptake responses that were only partly inhibited by PT (Figs. 2 and 3 ). Although these results contrast with findings that granulocyte responses to CF are sometimes totally blocked by PT, four points merit emphasis. First, PT can have nonspecific effects. We found, for example, that 16 g/ml of PT irreversibly clumped Eo. This led to total blockage of Eo random motility and migration responses, effects that cannot be related simply to GP inhibition. Second, the efficacy of PT in PMN (32, 33) and Eo (34 -36) sometimes depends on CF dosage, with high concentrations of CF typically overcoming the PT inhibition, even if total, that occurs at a lower CF concentration. Note that we observed PT completely blocked optimal doses of 5-oxoETE at levels only weakly blocking even suboptimal levels of other CF. Third, PT has response-selective effects (32) (33) (34) (35) (36) (37) , e.g., Ca 2ϩ transient responses to LTB 4 are not reduced under conditions in which migration responses are fully blocked by a given amount of PT (37) . Fourth, in any given assay, PT may inhibit some, but not other, GPCR. This is evidenced by studies in which PAF-induced Ca 2ϩ transients in PMN and Eo (32, 36, 37) and hexose uptake in PMN (Fig. 2) are not altered by PT at levels that block other CF. Indeed, CF commonly exhibit a wide range of PT sensitivities, and within this range PAF often occupies a position of extreme PT resistance (19, 22 (Fig. 6, Table II) . GTP␥S inhibited the binding of both radioligands, whereas ATP␥S had no such effect (Table II) . These results parallel those observed with partially purified plasma membranes from PMN (11) . Since FMLP, C5a, PAF, and IL-8 did not displace 5-oxoETE binding to plasma membranes (11) , and since LXA 4 and LXB 4 did not alter 5-oxoETE binding to mixed membranes (Fig. 6) , the 5-oxoETE binding site appears distinct from those for other granulocyte-stimulating eicosanoids and CF. 5-OxoETE induced these same mixed membrane preparations to incorporate [ 35 S]GTP␥S (Fig. 4) , a property characteristic of the GTP/GDP exchange reaction conducted by GPCR, such as those for CF. Indeed, other CF stimulated a similar exchange, but their effects proved insensitive to PT under conditions that fully abrogated the action of 5-oxoETE (Fig. 5) . Taken together, these results suggest PMN have a plasma membrane GPCR for 5-oxoETE. This putative GPCR resembles those for other CF in coupling to GP, but is unique in binding 5-oxoETE analogues rather than other eicosanoids or CF and in exhibiting exquisite PT sensitivity in selected functional and G protein activity assays. We stress that our PT treatment regimen used a limited incubation time (PMN incubated for Ͼ2 h, Ϯ PT, showed reduced responses to all CF), and accordingly may not have inactivated all PT-sensitive GP. Nonetheless, the data are compatible with the notion that putative 5-oxoETE receptors operate through G␣ i , while receptors for other CF have actions that go beyond this GP subfamily.
GPCR coupled to G i , but not those coupled to G q , activate MAPK, even though ␤␥-chains bear the responsibility for regulating MAPK in COS-7 and Rat-1 cells (38 -40) . Similarly, G icoupled, but not G q -coupled or G s -coupled, GPCR elicit chemotactic responses, although it is ␤␥-chains that mediate the motility responses of HEK293 cells (41, 42) . Such results imply that GPCR, including those for IL-8, can act independently of GP in genetically engineered cells (42) . Differences in the PT sensitivities of classical CF and 5-oxoETE would be explained if GPCR for the former agents have GP-independent effects, while the putative 5-oxoETE receptor acts strictly through GP. It is also possible that some G␣ i -chains, because of compartmentalization, contribute to function in PT-treated cells. In this scenario, PT (which under our conditions attacks only plasma membrane GP) would partly inhibit classical CF if they operate through both surface membrane and secondary granule-associated GP (Fig. 9 ), yet totally inhibit 5-oxoETE if it acts exclusively on plasmalemma GP. Alternatively, PT might target only a portion of plasma membrane G i ␣-chains, reducing their net activity below some threshold level needed to transmit the action of 5-oxoETE, but not below that needed by classical CF. These and other explanations do not stem from a difference in receptor density since receptors for 5-oxoETE are numerically comparable with those for LTB 4 (Fig. 7) and, by extrapolation, PAF and FMLP (43).
In conclusion, PMN membranes contain a site that binds 5-oxoETE analogues, but not LTB 4 , LXA 4 , LXB 4 , PAF, FMLP, C5a, or IL-8. This site resembles the receptors for other CF in that it couples to GP, as indicated by the effects of guanosine nucleotides on 5-oxoETE binding and the ability of 5-oxoETE analogues to stimulate GDP/GTP exchange. We hypothesize this site is a novel GPCR. The putative 5-oxoETE GPCR nonetheless differs from the GPCR for other CF receptors since it activates mainly, if not exclusively, PT-sensitive GP and displays uniquely high sensitivity to PT in PMN and Eo. The latter cells have PT-resistant ␣ q/11 -, ␣ 13 -, and/or, perhaps, ␣ 16 -in addition to PT-sensitive ␣ i2 -and, probably, ␣ i3 -chains. We accordingly also hypothesize the putative 5-oxoETE receptor preferentially couples to the G i subfamily, while receptors for other CF couple to not only this, but also G 12/13 and/or G q/11 subfamilies of GP. However, we cannot exclude a possibility that GPCR for the latter CF, but not 5-oxoETE receptors, have effects on PMN and Eo that bypass GP and thereby attain PT resistance. Regardless of this or other possibilities, the distinctive GP coupling of putative 5-oxoETE GPCR may explain the limited granulocyte-stimulating actions of 5-oxoETE analogues, and prove useful to probe the connections between particular receptors, GP subfamilies, cell signal pathways, and cell responses.
